glp-1 off label use GLP -1 and GIP Off-Label Uses & Maintenance Explained Beyond the Scale Ep. 4:

, : , , , .

Ashley Groffenbergercq, the citys chief financial officer, last week warned the City Council that without action, workers on one of the citys Blue Cross Blue Shield family insurance plans would see their monthly premium increase in July from $655 to $803, or roughly 23 percent the highest year-over-year increase in premium costs the city has seen in recent history. Groffenberger told the City Council that nearly 15 percent of the citys overall projected increase in health care costs is driven by the rise in city employees taking GLP-1 medications

Serious but uncommon risks include acute pancreatitis, gallbladder disease, and dehydration, requiring prompt medical attention if symptoms develop

When demand for GLP-1s and GIP/GLP-1s leaped past what the manufacturers could provide, compounded versions popped up in online pharmacies and brick-and-mortar stores, for the following drugs: Ozempic (semaglutide) Rybelsus (semaglutide) Wegovy (semaglutide) Zepbound (tirzepatide) Mounjaro (tirzepatide) Retatrutide (This drug is not FDA approved.) However, the FDA cautions that compounded drugs, while useful or even necessary in some situations, are not FDA-reviewed or approved, so the FDA cannot guarantee their safety, quality, or effectiveness

This allows businesses to grow without being constrained by their own manufacturing limitations

A Media Matters review found at least three weightloss telehealth companies Found Health, MD Exam, and Goglia Nutrition (G-Plans) are paying for deceptive ads on Meta selling generic or alternative options to the aforementioned medications